{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T09:05:44Z","timestamp":1789376744594,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["Agreement No. 075-15-2022-301"],"award-info":[{"award-number":["Agreement No. 075-15-2022-301"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Program at the Moscow State University (MSU) Institute for Artificial Intelligence"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"DOI":"10.1007\/s00011-026-02347-x","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:40:57Z","timestamp":1789375257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7577-628X","authenticated-orcid":false,"given":"A.","family":"Golovkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Markelova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1423-6562","authenticated-orcid":false,"given":"E. V.","family":"Ignatieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1916-5705","authenticated-orcid":false,"given":"O.","family":"Kalinina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6163-2162","authenticated-orcid":false,"given":"O. A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-9701","authenticated-orcid":false,"given":"D.","family":"Antonets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7587-1666","authenticated-orcid":false,"given":"Y.","family":"Medvedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Minin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Shtokalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-9509","authenticated-orcid":false,"given":"V.","family":"Ramensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7204-7850","authenticated-orcid":false,"given":"I.","family":"Kudryavtsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-3847","authenticated-orcid":false,"given":"O.","family":"Moiseeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7590-742X","authenticated-orcid":false,"given":"V.","family":"Myachikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Vyatkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lavrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2685-1623","authenticated-orcid":false,"given":"M.","family":"Samsonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2427-4148","authenticated-orcid":false,"given":"A.","family":"Maslyanskiy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9349-6257","authenticated-orcid":false,"given":"A.","family":"Kostareva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-0980","authenticated-orcid":false,"given":"E.","family":"Shlyakhto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"issue":"2","key":"2347_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jacbts.2020.11.016","volume":"6","author":"AG Mauro","year":"2021","unstructured":"Mauro AG, Bonaventura A, Vecchi\u00e9 A, Mezzaroma E, Carbone S, Narayan P, et al. The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approaches. JACC Basic Transl Sci. 2021;6(2):137\u201350. https:\/\/doi.org\/10.1016\/j.jacbts.2020.11.016.","journal-title":"JACC Basic Transl Sci"},{"issue":"105","key":"2347_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.3105cm1","volume":"3","author":"A Weber","year":"2010","unstructured":"Weber A, Wasiliew P, Kracht M. Interleukin-1 (IL-1) pathway. Sci Signal. 2010;3(105):1\u20137. https:\/\/doi.org\/10.1126\/scisignal.3105cm1.","journal-title":"Sci Signal"},{"issue":"5","key":"2347_CR3","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1002\/jcp.27436","volume":"234","author":"A Bonaventura","year":"2019","unstructured":"Bonaventura A, Montecucco F. Inflammation and pericarditis: are neutrophils actors behind the scenes? J Cell Physiol. 2019;234(5):5390\u20138. https:\/\/doi.org\/10.1002\/jcp.27436.","journal-title":"J Cell Physiol"},{"issue":"14","key":"2347_CR4","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/heartjnl-2019-316481","volume":"106","author":"P Cacoub","year":"2020","unstructured":"Cacoub P, Marques C. Acute recurrent pericarditis: from pathophysiology towards new treatment strategy. Heart. 2020;106(14):1046\u201351. https:\/\/doi.org\/10.1136\/heartjnl-2019-316481.","journal-title":"Heart"},{"issue":"10","key":"2347_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/hrt.2009.187138","volume":"96","author":"ALP Caforio","year":"2010","unstructured":"Caforio ALP, Brucato A, Doria A, Brambilla G, Angelini A, Ghirardello A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96(10):779\u201384. https:\/\/doi.org\/10.1136\/hrt.2009.187138.","journal-title":"Heart"},{"issue":"5","key":"2347_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tcm.2020.04.006","volume":"31","author":"G Lopalco","year":"2021","unstructured":"Lopalco G, Rigante D, Cantarini L, Imazio M, Lopalco A, Emmi G, et al. The autoinflammatory side of recurrent pericarditis: enlightening the pathogenesis for a more rational treatment. Trends Cardiovasc Med. 2021;31(5):265\u201374. https:\/\/doi.org\/10.1016\/j.tcm.2020.04.006.","journal-title":"Trends Cardiovasc Med"},{"issue":"1","key":"2347_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jacc.2019.11.021","volume":"75","author":"JG Chiabrando","year":"2020","unstructured":"Chiabrando JG, Bonaventura A, Vecchi\u00e9 A, Wohlford GF, Mauro AG, Jordan JH, et al. Management of acute and recurrent pericarditis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(1):76\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2019.11.021.","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"2347_CR8","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.2146\/ajhp140505","volume":"71","author":"L Chhabra","year":"2014","unstructured":"Chhabra L, Spodick DH. Colchicine for pericarditis. Am J Health Syst Pharm. 2014;71(23):2012\u20133.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"2347_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.tcm.2014.09.011","volume":"25","author":"M Imazio","year":"2015","unstructured":"Imazio M. Colchicine for pericarditis. Trends Cardiovasc Med. 2015;25(2):129\u201336. https:\/\/doi.org\/10.1016\/j.tcm.2014.09.011.","journal-title":"Trends Cardiovasc Med"},{"issue":"6","key":"2347_CR10","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","volume":"118","author":"M Imazio","year":"2008","unstructured":"Imazio M, Brucato A, Cumetti D, Brambilla G, Demichelis B, Ferro S, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118(6):667\u201371. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.761064.","journal-title":"Circulation"},{"issue":"12","key":"2347_CR11","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v2.i12.403","volume":"2","author":"P Farand","year":"2010","unstructured":"Farand P. Acute and recurring pericarditis: more colchicine, less corticosteroids. World J Cardiol. 2010;2(12):403. https:\/\/doi.org\/10.4330\/wjc.v2.i12.403.","journal-title":"World J Cardiol"},{"issue":"1","key":"2347_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ehjcvp\/pvx018","volume":"4","author":"LF Buckley","year":"2018","unstructured":"Buckley LF, Viscusi MM, Van Tassell BW, Abbate A. Interleukin-1 blockade for the treatment of pericarditis. Eur Hear J - Cardiovasc Pharmacother. 2018;4(1):46\u201353. https:\/\/doi.org\/10.1093\/ehjcvp\/pvx018.","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"issue":"6","key":"2347_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.autrev.2019.01.005","volume":"18","author":"A Dagan","year":"2019","unstructured":"Dagan A, Langevitz P, Shoenfeld Y, Shovman O. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. Autoimmun Rev. 2019;18(6):627\u201331. https:\/\/doi.org\/10.1016\/j.autrev.2019.01.005.","journal-title":"Autoimmun Rev"},{"issue":"00","key":"2347_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/crd.0000000000000704","volume":"XXX","author":"JM Feldman","year":"2024","unstructured":"Feldman JM, Frishman WH, Aronow WS. Goflikicept and related IL-1 inhibitors in the treatment of recurrent pericarditis. Cardiol Rev. 2024;XXX(00):10\u20133. https:\/\/doi.org\/10.1097\/crd.0000000000000704.","journal-title":"Cardiol Rev"},{"issue":"18","key":"2347_CR15","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2016.15826","volume":"316","author":"A Brucato","year":"2016","unstructured":"Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M, et al. Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial. JAMA. 2016;316(18):1906\u201312. https:\/\/doi.org\/10.1001\/jama.2016.15826.","journal-title":"JAMA"},{"issue":"9","key":"2347_CR16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0735-1097(19)31868-6","volume":"73","author":"A Klein","year":"2019","unstructured":"Klein A, Lin D, Cremer P, Nasir S, Crugnale S, Collins L, et al. Rilonacept in recurrent pericarditis: first efficacy and safety data from an ongoing phase 2 pilot clinical trial. J Am Coll Cardiol. 2019;73(9):1261.","journal-title":"J Am Coll Cardiol"},{"key":"2347_CR17","first-page":"A7","volume":"14","author":"A Dmitrieva","year":"2018","unstructured":"Dmitrieva A, Shipaeva E, Schedrova M, Scott M, Lavrovsky YSM. Nonclinical characterization of the novel IL-1 heterodimeric fusion protein RPH-104. Immunome Res. 2018;14:A7.","journal-title":"Immunome Res"},{"issue":"1","key":"2347_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jacc.2023.04.046","volume":"82","author":"VY Myachikova","year":"2023","unstructured":"Myachikova VY, Maslyanskiy AL, Moiseeva OM, Vinogradova OV, Gleykina EV, Lavrovsky Y, et al. Treatment of idiopathic recurrent pericarditis with goflikicept. J Am Coll Cardiol. 2023;82(1):30\u201340. https:\/\/doi.org\/10.1016\/j.jacc.2023.04.046.","journal-title":"J Am Coll Cardiol"},{"key":"2347_CR19","doi-asserted-by":"crossref","unstructured":"Jin ZS, Wang HY. Small molecules RSC001 use in breast cancer model. Immunome Res. 2018;14.","DOI":"10.4172\/1745-7580-C1-014"},{"issue":"7","key":"2347_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.124.069396","volume":"150","author":"A Abbate","year":"2024","unstructured":"Abbate A, Van Tassell B, Bogin V, Markley R, Pevzner DV, Cremer PC, et al. Results of international, double-blind, randomized, placebo-controlled, phase IIa study of interleukin-1 blockade with RPH-104 (Goflikicept) in patients with ST-segment-elevation myocardial infarction (STEMI). Circulation. 2024;150(7):580\u20132.","journal-title":"Circulation"},{"issue":"42","key":"2347_CR21","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Y Adler","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, Badano L, Bar\u00f3n-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921\u201364.","journal-title":"Eur Heart J"},{"issue":"2","key":"2347_CR22","first-page":"118","volume":"70","author":"J Pouchot","year":"1991","unstructured":"Pouchot J, Sampalis JS, Beaudet F, Carette S, D\u00e9cary F, Salusinsky-Sternbach M, et al. Adult still\u2019s disease: Manifestations, disease course, and outcome in 62 patients. Medicine (United States). 1991;70(2):118\u201336.","journal-title":"Medicine (United States)"},{"issue":"1","key":"2347_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-88219-6","volume":"15","author":"OA Ivanova","year":"2025","unstructured":"Ivanova OA, Predeus AV, Sorokina MY, Ignatieva EV, Bobkov DE, Sukhareva KS, et al. LMNA R482L mutation causes impairments in C2C12 myoblasts subpopulations, alterations in metabolic reprogramming during differentiation, and oxidative stress. Sci Rep. 2025;15(1):5358. https:\/\/doi.org\/10.1038\/s41598-025-88219-6.","journal-title":"Sci Rep"},{"issue":"1","key":"2347_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1382-0","volume":"19","author":"FA Wolf","year":"2018","unstructured":"Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol. 2018;19(1):15. https:\/\/doi.org\/10.1186\/s13059-017-1382-0.","journal-title":"Genome Biol"},{"issue":"12","key":"2347_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"2347_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41695-z","author":"VA Traag","year":"2019","unstructured":"Traag VA, Waltman L, van Eck NJ. From Louvain to Leiden: guaranteeing well-connected communities. Sci Rep. 2019. https:\/\/doi.org\/10.1038\/s41598-019-41695-z.","journal-title":"Sci Rep"},{"key":"2347_CR27","doi-asserted-by":"publisher","unstructured":"Heumos L, Ji Y, May L, Green T, Zhang X, Wu X, et al. Pertpy: an end-to-end framework for perturbation analysis. bioRxiv. 2024. p. 2024.08.04.606516. https:\/\/doi.org\/10.1101\/2024.08.04.606516","DOI":"10.1101\/2024.08.04.606516"},{"issue":"8","key":"2347_CR28","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1038\/s41596-021-00561-x","volume":"16","author":"JW Squair","year":"2021","unstructured":"Squair JW, Skinnider MA, Gautier M, Foster LJ, Courtine G. Prioritization of cell types responsive to biological perturbations in single-cell data with Augur. Nat Protoc. 2021;16(8):3836\u201373. https:\/\/doi.org\/10.1038\/s41596-021-00561-x.","journal-title":"Nat Protoc"},{"issue":"1","key":"2347_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21038-1","volume":"12","author":"KD Zimmerman","year":"2021","unstructured":"Zimmerman KD, Espeland MA, Langefeld CD. A practical solution to pseudoreplication bias in single-cell studies. Nat Commun. 2021;12(1):738. https:\/\/doi.org\/10.1038\/s41467-021-21038-1.","journal-title":"Nat Commun"},{"key":"2347_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bioadv\/vbac016","author":"P Badia-I-Mompel","year":"2022","unstructured":"Badia-I-Mompel P, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022. https:\/\/doi.org\/10.1093\/bioadv\/vbac016.","journal-title":"Bioinform Adv"},{"key":"2347_CR31","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202211517","author":"M Lotfollahi","year":"2023","unstructured":"Lotfollahi M, Klimovskaia Susmelj A, De Donno C, Hetzel L, Ji Y, Ibarra IL, et al. Predicting cellular responses to complex perturbations in high\u2010throughput screens. Mol Syst Biol. 2023. https:\/\/doi.org\/10.15252\/msb.202211517.","journal-title":"Mol Syst Biol"},{"issue":"6473","key":"2347_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.aax6234","volume":"367","author":"SR Srivatsan","year":"2020","unstructured":"Srivatsan SR, McFaline-Figueroa JL, Ramani V, Saunders L, Cao J, Packer J, et al. Massively multiplex chemical transcriptomics at single-cell resolution. Science. 2020;367(6473):45\u201351. https:\/\/doi.org\/10.1126\/science.aax6234.","journal-title":"Science"},{"key":"2347_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng GXY, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R, et al. Massively parallel digital transcriptional profiling of single cells. Nat Commun. 2017;8:14049. https:\/\/doi.org\/10.1038\/ncomms14049.","journal-title":"Nat Commun"},{"key":"2347_CR34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"2004","unstructured":"Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745\u201363. https:\/\/doi.org\/10.1146\/annurev.immunol.22.012703.104702.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"2347_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000324309","volume":"118","author":"G Lazaros","year":"2011","unstructured":"Lazaros G, Karavidas A, Spyropoulou M, Tsiachris D, Halapas A, Zacharoulis A, et al. The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Cardiology. 2011;118(1):55\u201362. https:\/\/doi.org\/10.1159\/000324309.","journal-title":"Cardiology"},{"issue":"2","key":"2347_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nri3384","volume":"13","author":"P Vantourout","year":"2013","unstructured":"Vantourout P, Hayday A. Six-of-the-best: unique contributions of \u03b3\u03b4 T cells to immunology. Nat Rev Immunol. 2013;13(2):88\u2013100. https:\/\/doi.org\/10.1038\/nri3384.","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"2347_CR37","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1182\/blood-2003-04-1016","volume":"102","author":"M Brandes","year":"2003","unstructured":"Brandes M, Willimann K, Lang AB, Nam KH, Jin C, Brenner MB, et al. Flexible migration program regulates \u03b3\u03b4 T-cell involvement in humoral immunity. Blood. 2003;102(10):3693\u2013701. https:\/\/doi.org\/10.1182\/blood-2003-04-1016.","journal-title":"Blood"},{"issue":"OCT","key":"2347_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2018.02389","volume":"9","author":"CM Shiromizu","year":"2018","unstructured":"Shiromizu CM, Jancic CC. \u03b3\u03b4 T lymphocytes: an effector cell in autoimmunity and infection. Front Immunol. 2018;9(OCT):1\u20138. https:\/\/doi.org\/10.3389\/fimmu.2018.02389.","journal-title":"Front Immunol"},{"issue":"9","key":"2347_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","volume":"20","author":"DI Godfrey","year":"2019","unstructured":"Godfrey DI, Koay HF, McCluskey J, Gherardin NA. The biology and functional importance of MAIT cells. Nat Immunol. 2019;20(9):1110\u201328. https:\/\/doi.org\/10.1038\/s41590-019-0444-8.","journal-title":"Nat Immunol"},{"issue":"4","key":"2347_CR40","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/ni.3679","volume":"18","author":"AN Keller","year":"2017","unstructured":"Keller AN, Eckle SBG, Xu W, Liu L, Hughes VA, Mak JYW, et al. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells. Nat Immunol. 2017;18(4):402\u201311. https:\/\/doi.org\/10.1038\/ni.3679.","journal-title":"Nat Immunol"},{"issue":"4","key":"2347_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/08916934.2016.1148692","volume":"49","author":"KL Crossland","year":"2016","unstructured":"Crossland KL, Abinun M, Arkwright PD, Cheetham TD, Pearce SH, Hilkens CMU, et al. AIRE is not essential for the induction of human tolerogenic dendritic cells. Autoimmunity. 2016;49(4):211\u20138. https:\/\/doi.org\/10.3109\/08916934.2016.1148692.","journal-title":"Autoimmunity"},{"issue":"12","key":"2347_CR42","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41590-025-02319-z","volume":"26","author":"L Vande Walle","year":"2025","unstructured":"Vande Walle L, Kato K, Yamagishi M, Kamatani T, Vervaeke A, Mart\u00edn-P\u00e9rez R, et al. Single-cell analysis reveals cell death as driver of NLRP3-mediated secretion of IL-1\u03b2 in human monocytes. Nat Immunol. 2025;26(12):2148\u201358. https:\/\/doi.org\/10.1038\/s41590-025-02319-z.","journal-title":"Nat Immunol"},{"issue":"2","key":"2347_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","volume":"34","author":"G Guarda","year":"2011","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, F\u00f6rster I, et al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213\u201323. https:\/\/doi.org\/10.1016\/j.immuni.2011.02.006.","journal-title":"Immunity"},{"issue":"6","key":"2347_CR44","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202302399","volume":"7","author":"R D\u00edaz-Pino","year":"2024","unstructured":"D\u00edaz-Pino R, Rice GI, San Felipe D, Pepanashvili T, Kasher PR, Briggs TA, et al. Type I interferon regulates interleukin-1beta and IL-18 production and secretion in human macrophages. Life Sci Alliance. 2024;7(6):e202302399. https:\/\/doi.org\/10.26508\/lsa.202302399.","journal-title":"Life Sci Alliance"},{"key":"2347_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1219870","author":"MF Gjerstorff","year":"2023","unstructured":"Gjerstorff MF. Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1219870.","journal-title":"Front Immunol"},{"issue":"1","key":"2347_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/cmi.2016.25","volume":"14","author":"KD Mayer-Barber","year":"2017","unstructured":"Mayer-Barber KD, Yan B. Clash of the cytokine titans: counter-regulation of interleukin-1 and type i interferon-mediated inflammatory responses. Cell Mol Immunol. 2017;14(1):22\u201335. https:\/\/doi.org\/10.1038\/cmi.2016.25.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"2347_CR47","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1089\/jir.1988.8.559","volume":"8","author":"M Kohase","year":"1988","unstructured":"Kohase M, Zhang Y, Lin JX, Vil\u010dek J, Kohase M, Yamazaki S, et al. Interleukin-1 can inhibit interferon-\u03b2 synthesis and its antiviral action: comparison with tumor necrosis factor. J Interferon Res. 1988;8(4):559\u201370. https:\/\/doi.org\/10.1089\/jir.1988.8.559.","journal-title":"J Interferon Res"},{"issue":"7507","key":"2347_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature13489","volume":"511","author":"KD Mayer-Barber","year":"2014","unstructured":"Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, et al. Host-directed therapy of tuberculosis based on interleukin-1 and type i interferon crosstalk. Nature. 2014;511(7507):99\u2013103. https:\/\/doi.org\/10.1038\/nature13489.","journal-title":"Nature"},{"issue":"1","key":"2347_CR49","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41590-019-0559-y","volume":"21","author":"A Jain","year":"2020","unstructured":"Jain A, Irizarry-Caro RA, McDaniel MM, Chawla AS, Carroll KR, Overcast GR, et al. T cells instruct myeloid cells to produce inflammasome-independent IL-1\u03b2 and cause autoimmunity. Nat Immunol. 2020;21(1):69. https:\/\/doi.org\/10.1038\/s41590-019-0559-y.","journal-title":"Nat Immunol"},{"key":"2347_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05489-7","author":"A Jain","year":"2018","unstructured":"Jain A, Song R, Wakeland EK, Pasare C. T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells. Nat Commun. 2018. https:\/\/doi.org\/10.1038\/s41467-018-05489-7.","journal-title":"Nat Commun"},{"issue":"5","key":"2347_CR51","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/imcb.12021","volume":"96","author":"NA Gherardin","year":"2018","unstructured":"Gherardin NA, Souter MNT, Koay HF, Mangas KM, Seemann T, Stinear TP, et al. Human blood MAIT cell subsets defined using MR1 tetramers. Immunol Cell Biol. 2018;96(5):507\u201325. https:\/\/doi.org\/10.1111\/imcb.12021.","journal-title":"Immunol Cell Biol"},{"issue":"4","key":"2347_CR52","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","volume":"117","author":"M Dusseaux","year":"2011","unstructured":"Dusseaux M, Martin E, Serriari N, P\u00e9guillet I, Premel V, Louis D, et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161 hi IL-17-secreting T cells. Blood. 2011;117(4):1250\u20139. https:\/\/doi.org\/10.1182\/blood-2010-08-303339.","journal-title":"Blood"},{"issue":"1","key":"2347_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/eji.201343509","volume":"44","author":"JE Ussher","year":"2014","unstructured":"Ussher JE, Bilton M, Attwod E, Shadwell J, Richardson R, de Lara C, et al. CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol. 2014;44(1):195\u2013203. https:\/\/doi.org\/10.1002\/eji.201343509.","journal-title":"Eur J Immunol"},{"issue":"1","key":"2347_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11653","volume":"7","author":"B van Wilgenburg","year":"2016","unstructured":"van Wilgenburg B, Scherwitzl I, Hutchinson EC, Leng T, Kurioka A, Kulicke C, et al. MAIT cells are activated during human viral infections. Nat Commun. 2016;7(1):11653. https:\/\/doi.org\/10.1038\/ncomms11653.","journal-title":"Nat Commun"},{"issue":"AUG","key":"2347_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01031","volume":"8","author":"A Kurioka","year":"2017","unstructured":"Kurioka A, Jahun AS, Hannaway RF, Walker LJ, Fergusson JR, Sverremark-Ekstr\u00f6m E, et al. Shared and distinct phenotypes and functions of human cD161++ V\u03b17.2+ T cell subsets. Front Immunol. 2017;8(AUG):1031. https:\/\/doi.org\/10.3389\/fimmu.2017.01031.","journal-title":"Front Immunol"},{"issue":"8","key":"2347_CR56","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.4049\/jimmunol.1700615","volume":"199","author":"M Salio","year":"2017","unstructured":"Salio M, Gasser O, Gonzalez-Lopez C, Martens A, Veerapen N, Gileadi U, et al. Activation of human mucosal-associated invariant T cells induces CD40L-dependent maturation of monocyte-derived and primary dendritic cells. J Immunol. 2017;199(8):2631\u20138. https:\/\/doi.org\/10.4049\/jimmunol.1700615.","journal-title":"J Immunol"},{"issue":"9","key":"2347_CR57","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1038\/sj.onc.1206126","volume":"22","author":"S Baumann","year":"2003","unstructured":"Baumann S, Hess J, Eichhorst ST, Krueger A, Angel P, Krammer PH, et al. An unexpected role for FosB in activation-induced cell death of T cells. Oncogene. 2003;22(9):1333\u20139. https:\/\/doi.org\/10.1038\/sj.onc.1206126.","journal-title":"Oncogene"},{"key":"2347_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151956","author":"TB van der Houwen","year":"2022","unstructured":"van der Houwen TB, van Hagen PM, van Laar JAM. Immunopathogenesis of Beh\u00e7et\u2019s disease and treatment modalities. Semin Arthritis Rheum. 2022. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151956.","journal-title":"Semin Arthritis Rheum"},{"issue":"JAN","key":"2347_CR59","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fimmu.2014.00657","volume":"6","author":"C Harly","year":"2015","unstructured":"Harly C, Peign\u00e9 CM, Scotet E. Molecules and mechanisms implicated in the peculiar antigenic activation process of human V\u03b39V\u03b42 T cells. Front Immunol. 2015;6(JAN):657. https:\/\/doi.org\/10.3389\/fimmu.2014.00657.","journal-title":"Front Immunol"},{"key":"2347_CR60","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2017.11.006","volume":"87","author":"PH Papotto","year":"2018","unstructured":"Papotto PH, Reinhardt A, Prinz I, Silva-Santos B. Innately versatile: \u03b3\u03b417 T cells in inflammatory and autoimmune diseases. J Autoimmun. 2018;87:26\u201337. https:\/\/doi.org\/10.1016\/j.jaut.2017.11.006.","journal-title":"J Autoimmun"},{"issue":"1","key":"2347_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/blood-2011-01-331298","volume":"118","author":"N Caccamo","year":"2011","unstructured":"Caccamo N, La Mendola C, Orlando V, Meraviglia S, Todaro M, Stassi G, et al. Differentiation, phenotype, and function of interleukin-17-producing human v\u03b39v\u03b42 T cells. Blood. 2011;118(1):129\u201338. https:\/\/doi.org\/10.1182\/blood-2011-01-331298.","journal-title":"Blood"},{"issue":"7","key":"2347_CR62","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.immuni.2023.05.014","volume":"56","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang J, Zheng W, Zhang J, Wang J, Jin T, et al. Identification of an IL-1 receptor mutation driving autoinflammation directs IL-1-targeted drug design. Immunity. 2023;56(7):1485-1501.e7. https:\/\/doi.org\/10.1016\/j.immuni.2023.05.014.","journal-title":"Immunity"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-026-02347-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-026-02347-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:41:02Z","timestamp":1789375262000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-026-02347-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2347"],"URL":"https:\/\/doi.org\/10.1007\/s00011-026-02347-x","relation":{},"ISSN":["1420-908X"],"issn-type":[{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Lavrovsky Y. and Samsonov M. are employees of RPharm company, manufacturing goflikicept. The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"214"}}